Investigation of Beckett–Casy model 3: Synthesis of novel naltrexone derivatives with contracted and expanded D-rings and their pharmacology-Reference-Cited by-同舟云学术

Investigation of Beckett–Casy model 3: Synthesis of novel naltrexone derivatives with contracted and expanded D-rings and their pharmacology

Published:2010-06 Issue:12 Volume:20 Page:3801-3804
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Nagase Hiroshi,Imaide Satomi,Tomatsu Miyuki,Hirayama Shigeto,Nemoto Toru,Sato Noriko,Nakajima Mayumi,Nakao Kaoru,Mochizuki Hidenori,Gouda Hiroaki,Hirono Shuichi,Fujii Hideaki

Funder

Scientific Research

Shorai Foundation for Science

Uehara Memorial Foundation

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference34 articles.

1. Discovery of a Structurally Novel Opioid .KAPPA.-Agonist Derived from 4,5-Epoxymorphinan.

2. Rational Drug Design and Synthesis of a Highly Selective Nonpeptide .DELTA.-Opioid Agonist, (4aS*,12aR*)-4a-(3-Hydroxyphenyl)-2-methyl-1,2,3,4,4a,5,12,12a-octahydropyrido[3,4-b]acridine (TAN-67).

3. Synthesis of a novel 6,14-epoxymorphinan derivative and its pharmacology

4. Design, synthesis, and structure–activity relationship of novel opioid κ-agonists

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Essential structure of orexin 1 receptor antagonist YNT-707: Conversion of the 16-cyclopropylmethyl group to the 16-sulfonamide group in d-nor-nalfurafine derivatives;Bioorganic & Medicinal Chemistry Letters;2022-03

2. Effect of removal of the 14-hydroxy group on the affinity of the 4,5-epoxymorphinan derivatives for orexin and opioid receptors;Bioorganic & Medicinal Chemistry Letters;2022-03

3. Discovery of attenuation effect of orexin 1 receptor to aversion of nalfurafine: Synthesis and evaluation of D-nor-nalfurafine derivatives and analyses of the three active conformations of nalfurafine;Bioorganic & Medicinal Chemistry Letters;2020-09

4. Synthesis and evaluation of novel opioid ligands with a C-homomorphinan skeleton;Bioorganic & Medicinal Chemistry;2016-05

5. Transformation of naltrexone into mesembrane and investigation of the binding properties of its intermediate derivatives to opioid receptors;Bioorganic & Medicinal Chemistry;2015-02